title: Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?
abstract: By virtue of insulin resistance being the common etiology for polycystic ovary syndrome (PCOS) and metabolic syndrome, the cardiometabolic risks of these two syndromes are shared. The usual concerns of a PCOS patient are cosmetic or reproductive. However, there are more serious concerns past the reproductive age. Early treatment of insulin resistance, hypertension and hyperlipidemia reduces the long-term risk. This review highlights the unhealthy association of metabolic syndrome with PCOS and emphasizes the importance of early diagnosis, patient education and long-term follow-up beyond the reproductive age into menopause to prevent the long-term serious co-morbidities.
authors.affiliation: a Gynaecworld - the Center for Women's Health and Fertility , Mumbai , India.
authors.forename: D
authors.initials: D
authors.lastname: Shah
authors.affiliation: a Gynaecworld - the Center for Women's Health and Fertility , Mumbai , India.
authors.forename: S
authors.initials: S
authors.lastname: Rasool
mesh_terms: D050171:Dyslipidemias / Q000150:complications; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000150:complications* / Q000175:diagnosis; D009765:Obesity / Q000150:complications; D010353:Patient Education as Topic; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000175:diagnosis; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012891:Sleep Apnea Syndromes / Q000150:complications; D014944:World Health Organization
keywords: Polycystic ovary syndrome; dyslipidemia; hyperandrogenemia; hypertension; insulin resistance; menopause; metabolic syndrome; sleep apnea